References
- Godoy P, Hewitt NJ, Albrecht U, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013;87(8):1315–1530.
- Starokozhko V, Hemmingsen M, Larsen L, et al. Functional characterization of human induced pluripotent stem cell-derived hepatocytes differentiated at flow conditions using human precision-cut liver slices as benchmark. The Toxicologist. 2016;150(1):234–235.
- Prot JM, Bunescu A, Elena-Herrmann B, et al. Predictive toxicology using systemic biology and liver microfluidic “on chip” approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012;259(3):270–280.
- Prill S, Bavli D, Levy G, et al. Real-time monitoring of oxygen uptake in hepatic bioreactor shows CYP450-independent mitochondrial toxicity of acetaminophen and amiodarone. Arch Toxicol. 2016;90(5):1181–1191.
- van Midwoud PM, Janssen J, Merema MT, et al. On-line HPLC analysis system for metabolism and inhibition studies in precision-cut liver slices. Anal Chem. 2011;83(1):84–91.
- Usta OB, McCarty WJ, Bale S, et al. Microengineered cell and tissue systems for drug screening and toxicology applications: evolution of in-vitro liver technologies. Technology. 2015;3(1):1–26.
- Khetani SR, Berger DR, Ballinger KR, et al. Microengineered liver tissues for drug testing. J Lab Autom. 2015;20(3):216–250.
- Ma C, Zhao L, Zhou EM, et al. On-chip construction of liver lobule-like microtissue and its application for adverse drug reaction assay. Anal Chem. 2016;88(3):1719–1727.
- van Midwoud PM, Merema MT, Verpoorte E, et al. A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices. Lab on a Chip. 2010;10(20):2778–2786.
- Esch MB, Mahler GJ, Stokol T, et al. Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. Lab on a Chip. 2014;14(16):3081–3092.
- Maschmeyer I, Lorenz AK, Schimek K, et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab on a Chip. 2015;15(12):2688–2699.
- Esch MB, Ueno H, Applegate DR, et al. Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue. Lab on a Chip. 2016;16(14):2719–2729.
- Materne EM, Tonevitsky AG, Marx U. Chip-based liver equivalents for toxicity testing–organotypicalness versus cost-efficient high throughput. Lab on a Chip. 2013;13(18):3481–3495.
- Bale SS, Vernetti L, Senutovitch N, et al. In vitro platforms for evaluating liver toxicity. Exp Biol Med. 2014;239(9):1180–1191.
- Shintu L, Baudoin R, Navratil V, et al. Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs. Anal Chem. 2012;84(4):1840–1848.